AAAAAA

   
Results: 1-3 |
Results: 3
In vitro evaluation of an enhanced human serum amyloid a (SAA2) promoter-regulated soluble TNF receptor fusion protein for anti-inflammatory gene therapy
Authors: Rygg, M Uhlar, CM Thorn, C Jensen, LE Gaughan, DJ Varley, AW Munford, RS Goke, R Chen, Y Whitehead, AS
Citation: M. Rygg et al., In vitro evaluation of an enhanced human serum amyloid a (SAA2) promoter-regulated soluble TNF receptor fusion protein for anti-inflammatory gene therapy, SC J IMMUN, 53(6), 2001, pp. 588-595
The kinetics and magnitude of the synergistic activation of the serum amyloid A promoter by IL-1 beta and IL-6 is determined by the order of cytokineaddition
Authors: Uhlar, CM Whitehead, AS
Citation: Cm. Uhlar et As. Whitehead, The kinetics and magnitude of the synergistic activation of the serum amyloid A promoter by IL-1 beta and IL-6 is determined by the order of cytokineaddition, SC J IMMUN, 49(4), 1999, pp. 399-404
Serum amyloid A, the major vertebrate acute-phase reactant
Authors: Uhlar, CM Whitehead, AS
Citation: Cm. Uhlar et As. Whitehead, Serum amyloid A, the major vertebrate acute-phase reactant, EUR J BIOCH, 265(2), 1999, pp. 501-523
Risultati: 1-3 |